NM_025243.4:c.980-4delT
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_025243.4(SLC19A3):c.980-4delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 68683 hom., cov: 0)
Exomes 𝑓: 0.99 ( 723316 hom. )
Consequence
SLC19A3
NM_025243.4 splice_region, intron
NM_025243.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0760
Publications
10 publications found
Genes affected
SLC19A3 (HGNC:16266): (solute carrier family 19 member 3) This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010]
SLC19A3 Gene-Disease associations (from GenCC):
- biotin-responsive basal ganglia diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- infantile spams-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Leigh syndrome with leukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thiamine-responsive encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-227696084-GA-G is Benign according to our data. Variant chr2-227696084-GA-G is described in ClinVar as Benign. ClinVar VariationId is 215155.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_025243.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC19A3 | NM_025243.4 | MANE Select | c.980-4delT | splice_region intron | N/A | NP_079519.1 | |||
| SLC19A3 | NM_001371411.1 | c.980-4delT | splice_region intron | N/A | NP_001358340.1 | ||||
| SLC19A3 | NM_001371412.1 | c.980-4delT | splice_region intron | N/A | NP_001358341.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC19A3 | ENST00000644224.2 | MANE Select | c.980-4delT | splice_region intron | N/A | ENSP00000495385.1 | |||
| SLC19A3 | ENST00000258403.8 | TSL:1 | c.980-4delT | splice_region intron | N/A | ENSP00000258403.3 | |||
| SLC19A3 | ENST00000425817.6 | TSL:1 | n.*1005-4delT | splice_region intron | N/A | ENSP00000397393.2 |
Frequencies
GnomAD3 genomes AF: 0.947 AC: 143939AN: 152024Hom.: 68660 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
143939
AN:
152024
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.986 AC: 247116AN: 250528 AF XY: 0.990 show subpopulations
GnomAD2 exomes
AF:
AC:
247116
AN:
250528
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.995 AC: 1453354AN: 1461204Hom.: 723316 Cov.: 0 AF XY: 0.995 AC XY: 723698AN XY: 726984 show subpopulations
GnomAD4 exome
AF:
AC:
1453354
AN:
1461204
Hom.:
Cov.:
0
AF XY:
AC XY:
723698
AN XY:
726984
show subpopulations
African (AFR)
AF:
AC:
27066
AN:
33434
American (AMR)
AF:
AC:
44286
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
AC:
26129
AN:
26130
East Asian (EAS)
AF:
AC:
39684
AN:
39684
South Asian (SAS)
AF:
AC:
86213
AN:
86246
European-Finnish (FIN)
AF:
AC:
53412
AN:
53412
Middle Eastern (MID)
AF:
AC:
5724
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
1111285
AN:
1111484
Other (OTH)
AF:
AC:
59555
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
349
698
1046
1395
1744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21652
43304
64956
86608
108260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.947 AC: 144021AN: 152142Hom.: 68683 Cov.: 0 AF XY: 0.949 AC XY: 70610AN XY: 74392 show subpopulations
GnomAD4 genome
AF:
AC:
144021
AN:
152142
Hom.:
Cov.:
0
AF XY:
AC XY:
70610
AN XY:
74392
show subpopulations
African (AFR)
AF:
AC:
33789
AN:
41442
American (AMR)
AF:
AC:
14948
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
3470
AN:
3470
East Asian (EAS)
AF:
AC:
5176
AN:
5176
South Asian (SAS)
AF:
AC:
4816
AN:
4818
European-Finnish (FIN)
AF:
AC:
10602
AN:
10602
Middle Eastern (MID)
AF:
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
AC:
67978
AN:
68030
Other (OTH)
AF:
AC:
2037
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
321
642
962
1283
1604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
ClinVar submissions as Germline
View on ClinVar Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
Biotin-responsive basal ganglia disease (3)
-
-
2
not provided (2)
-
-
1
Thiamine Metabolism Dysfunction Syndrome (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.